Tempus cites real-world UK NHS study showing prostate pathology AI changes diagnosis in 5% of cases - TEM News | RalliesTempus cites real-world UK NHS study showing prostate pathology AI changes diagnosis in 5% of cases
T
TEM• Study highlights on prostate pathology AI in UK NHS deployment
- Tempus highlighted a Nature Digital Medicine study on real-world UK NHS deployment of the Paige Prostate AI Suite in prostate biopsy reporting.
- AI-assisted review led pathologists to change the initial diagnosis or Grade Group for 5% of patients; 1.3% could have altered clinical management.
- Labs reported faster turnaround times, with results potentially delivered nearly one day sooner than standard workflows.
- The study cited fewer requests for additional immunohistochemistry staining, indicating potential workflow relief for digital pathology labs.
•
